XT
LPCN icon

XTX Topco’s Lipocine LPCN Stock Holding History

XTX Topco’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,923
Closed -$143K – 4473
2026
Q1 		$143K Buy
+17,923
New +$156K ﹤0.01% 2979
2022
Q2 		– Sell
-2,315
Closed -$54K – 983
2022
Q1 		$54K Buy
+2,315
New +$48.4K 0.02% 583
2021
Q4 		– Sell
-1,692
Closed -$31K – 862
2021
Q3 		$31K Buy
1,692
+474
+39% +$10.5K 0.01% 631
2021
Q2 		$29K Sell
1,218
-543
-31% -$12.8K 0.01% 749
2021
Q1 		$45K Buy
+1,761
New +$50.8K 0.02% 627

Other funds holding LPCN

SCM
Squadron Capital Management Westmont, Illinois $322M AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

XTX Topco's LPCN Position: Q2 2026 in Review

XTX Topco sold out of Lipocine (LPCN) in Q2 2026, closing a stake of 17,923 shares — an estimated $143K sold.

XTX Topco first reported a position in LPCN in Q1 2021 and held it in 5 quarters. The position peaked at $143K in Q1 2026. 36 funds tracked by Wall St. Rank hold LPCN as of Q2 2026.

  • XTX Topco reported no remaining Lipocine position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 17,923 Lipocine shares in Q2 2026, an estimated $143K.
  • XTX Topco first reported a position in Lipocine in Q1 2021 and held it in 5 quarters.
  • XTX Topco's Lipocine position peaked at $143K in Q1 2026.
  • 36 funds tracked by Wall St. Rank held Lipocine as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.